Phase II study of vinflunine in patients with metastatic renal cell carcinoma

By Goldstein D.   Ackland S.   Bell D.   Olver I.   Davis I.   Rosenthal M.   Toner G.   Pinel M.   Byrne M.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 429-434

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of imatinib (Gleevec®) in patients with metastatic renal cell carcinoma

By Vuky Jacqueline   Isacson Christina   Fotoohi Mehran   Cruz Jason   Otero Henry   Picozzi Vincent   Malpass Thomas   Aboulafia David   Jacobs Andrew  

Investigational New Drugs, Vol. 24, Iss. 1, 2006-01 ,pp. : 85-88

Springer Publishing Company

Access to resources Recommend Favorite

Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma

By Sfoungaristos Stavros   Giannitsas Konstantinos   Perimenis Petros  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. : 533-547

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma

By Huie Michael   Oettel Kurt   Ummersen Lynn   Kim Kyung   Zhang Yulin   Staab Mary   Horvath Dottie   Marnocha Rebecca   Douglas Jeff   Drezen Amy   Alberti Dona   Wilding George  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate

By Bruce Justine  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 794-802

Springer Publishing Company

Access to resources Recommend Favorite